Literature DB >> 34002071

ADC sacituzumab govitecan shows efficacy and safety.

Peter Sidaway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34002071     DOI： 10.1038/s41585-021-00479-9

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).

Authors:  Jonathan E Rosenberg; Karla A Ballman; Susan Halabi; Pamela J Atherton; Amir Mortazavi; Christopher Sweeney; Walter M Stadler; Benjamin A Teply; Joel Picus; Scott T Tagawa; Sreedhar Katragadda; Daniel Vaena; Jamal Misleh; Christopher Hoimes; Elizabeth R Plimack; Thomas W Flaig; Robert Dreicer; Dean Bajorin; Olwen Hahn; Eric J Small; Michael J Morris
Journal:  J Clin Oncol       Date:  2021-05-14       Impact factor: 50.717
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.